NCT04617522 2026-02-11
Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment
Gilead Sciences
Phase 1 Recruiting
Gilead Sciences
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
Third Affiliated Hospital, Sun Yat-Sen University